Search results

Found 2,264 pages
AUTHOR: Lynne Taylor

15 Dec 2011:

NICE final "no" for AstraZeneca's Faslodex

In final guidance, the National Institute for Health and Clinical Excellence (NICE) says that widespread use of AstraZeneca's breast cancer drug Faslodex (fulvestrant) would not be an effective use of NHS resources. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/nice_final_no_for_astrazenecas_faslodex_979888

13 Sep 2011:

SMC OKs Celgene's Vidaza for MDS

The Scottish Medicines Consortium (SMC) has approved the use of Celgene's Vidaza (azacitidine) in patients with advanced myelodysplastic syndromes (MDS). - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/smc_oks_celgenes_vidaza_for_mds_980409

6 Aug 2008:

EMEA plans to test parallel imports

The European Medicines Agency is planning to include parallel-imported medicines in its annual Sampling and Testing Programme of centrally-authorised products (CAPs). - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/emea_plans_to_test_parallel_imports_988129

28 Jul 2009:

Philippines forces 50% price cuts for five drugs

The Philippines government has today announced mandatory 50% price cuts for five essential drugs, rejecting their makers’ offers of lower reductions. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/philippines_forces_50_price_cuts_for_five_drugs_983942

17 Aug 2010:

NICE to develop nine new quality standards

The National Institute for Health and Clinical Excellence (NICE) has announced that it will be developing nine new quality standards during 2010/11. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/nice_to_develop_nine_new_quality_standards_982589

26 Jul 2013:

EU probes German pharma aid plan

The European Commission has opened an "in-depth" inquiry into a scheme offering assistance to German pharmaceutical companies which are in financial difficulties. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/eu_probes_german_pharma_aid_plan_1005444

19 Oct 2012:

Australia launches review of pharma patent extensions

Australia's federal government has begun a review of the "appropriateness" of the current extension arrangements for pharmaceutical patents.  - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/australia_launches_review_of_pharma_patent_extensions_976409

18 Aug 2009:

Philippines’ drug price warning

Prices of a number of essential drugs in the Philippines have now been halved, and manufacturers - not retailers - must shoulder any price differentials, the government has said. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/philippines_drug_price_warning_983806

12 Oct 2010:

Qatar abolishes drug price-fixing

Qatar is to abolish government controls on medicines prices and open up the market to competition, in order to tackle current drug shortages and high price levels. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/qatar_abolishes_drug_price-fixing_982272

7 Jul 2011:

Takeda launches new presentation of Prostap

Takeda UK has announced the launch of a new presentation of Prostap, its treatment for prostate cancer in men and endometriosis and uterine fibroids in women. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/takeda_launches_new_presentation_of_prostap_980760